Drug Profile
Carvedilol/lisinopril
Alternative Names: Coreg CR + ACEi; COREG CR and lisinopril (FDC); COREG CR/Zestril; Lisinopril/carvedilol; Zestril/COREG CRLatest Information Update: 02 Jul 2023
Price :
$50
*
At a glance
- Originator GlaxoSmithKline
- Developer GSK
- Class Antihypertensives; Carbazoles; Heart failure therapies; Propanolamines
- Mechanism of Action ACE inhibitors; Alpha 1 adrenergic receptor antagonists; Alpha beta adrenergic receptor antagonists; Beta-adrenergic receptor antagonists; Calcium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Hypertension
Most Recent Events
- 30 Sep 2007 Phase-III clinical trials in Hypertension (PO)